The Coeliac Bank Transfer System provides a quarterly allowance through a direct bank transfer to patients’ bank accounts, enabling them to purchase gluten-free food products. Introduced in early 2026, this system replaces the previous vouchering system, reducing bureaucratic procedure and providing a simpler, more efficient process for eligible patients.
At time of reporting, the approximate number of patients benefiting from this scheme is 2,200.